SCHEMBL3419255

SCHEMBL3419255

COC(=O)C(C)c1cccc(-c2ccc(OC)c(CNC(=O)OC(C)(C)C)c2)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 2/20 0.48
PPARG P37231 3/20 0.43
PPARD Q03181 3/20 0.43
PPARA Q07869 3/20 0.43
ITGA4 P13612 1/20 0.40
ITGB7 P26010 1/20 0.40
PTGS1 P23219 1/20 0.40
PTGS2 P35354 1/20 0.40
HDAC1 Q13547 1/20 0.39
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
KCNA5 P22460 1/20 0.38
GFER P55789 1/20 0.38
HSD17B10 Q99714 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
HTT P42858 2/20 0.38
ITGB3 P05106 1/20 0.37
ITGAV P06756 1/20 0.37
PDCD1 Q15116 1/20 0.37
CD274 Q9NZQ7 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3418629 0.81 PPARA (0.45) TRPV1PPARGPPARDPPARAITGA4
SCHEMBL3415307 0.81 PPARD (0.63) PPARGPPARDPPARAHDAC1MEN1
SCHEMBL3416346 0.81 PPARG (0.53) TRPV1PPARGPPARDPPARAHDAC1
SCHEMBL6726294 0.81 PPARG (0.46) TRPV1PPARGPPARDPPARAPTGS2
SCHEMBL3413467 0.80 PTGS2 (0.46) PPARGPPARDPPARAPTGS1PTGS2
SCHEMBL3413605 0.80 PPARG (0.45) TRPV1PPARGPPARDPPARAITGA4
SCHEMBL3416367 0.79 PPARG (0.44) TRPV1PPARGPPARDPPARAITGA4
SCHEMBL3416314 0.77 PPARA (0.49) PPARGPPARDPPARAPTGS2HDAC1
SCHEMBL3413999 0.77 EGFR (0.41) TRPV1PPARGPPARDPPARAHDAC1
SCHEMBL3416004 0.77 PPARA (0.51) PPARGPPARDPPARAITGA4ITGB7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7687664-B2 Carboxylic acid derivative, a salt thereof or an ester of them, and medicament comprising it EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-03-30 US disclosed
US-20040214888-A1 Carboxylic acid derivative and medicine comprising salt or ester of the same EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-10-28 US disclosed
EP-1394147-A1 CARBOXYLIC ACID DERIVATIVE AND MEDICINE COMPRISING SALT OR ESTER OF THE SAME Eisai Co., Ltd. (JP) 2004-03-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040214888-A1 Carboxylic acid derivative and medicine comprising salt or ester of the same GPR119, NR3C1, INSR TRPV1 3091/4885PPARG 238/4885PPARD 689/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.